Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2003

Chiarle R, Gong JZ, Guasparri I, Pesci A, Cai J, Liu J, et al. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood. 2003;101(5):1919-27.

Ding R, Li B, Muthukumar T, Dadhania D, Medeiros M, Hartono C, et al. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation. 2003;75(8):1307-12.

Rand JH. The antiphospholipid syndrome. Annu Rev Med. 2003;54:409-24.

Huang XG, Yee BK, Nag S, Chan ST, Tang F. Behavioral and neurochemical characterization of transgenic mice carrying the human presenilin-1 gene with or without the leucine-to-proline mutation at codon 235. Exp Neurol. 2003;183(2):673-81.

Nash JW, Ross P, A Crowson N, Taylor J, Morales JE, Yunger TM, et al. The histopathologic spectrum of cryofibrinogenemia in four anatomic sites. Skin, lung, muscle, and kidney. Am J Clin Pathol. 2003;119(1):114-22.

Bonello L, Voena C, Ladetto M, Boccadoro M, Palestro G, Inghirami G, et al. BRAF gene is not mutated in plasma cell leukemia and multiple myeloma. Leukemia. 2003;17(11):2238-40.

Magro CM, Nuovo GJ, A Crowson N. The utility of the in situ detection of T-cell receptor Beta rearrangements in cutaneous T-cell-dominant infiltrates. Diagn Mol Pathol. 2003;12(3):133-41.

Allen EA, Parwani AV, Siddiqui MT, Clark DP, Ali SZ. Cytopathologic findings in breast masses in men with HIV infection. Acta Cytol. 2003;47(2):183-7.

Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, et al. Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma. J Clin Oncol. 2003;21(16):3051-9.

Lesinski GB, Anghelina M, Zimmerer J, Bakalakos T, Badgwell B, Parihar R, et al. The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J Clin Invest. 2003;112(2):170-80.